Capital International Investors Invests $97.08 Million in Cardinal Health, Inc. $CAH

Capital International Investors acquired a new position in Cardinal Health, Inc. (NYSE:CAH) in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 472,416 shares of the company’s stock, valued at approximately $97,081,000. Capital International Investors owned about 0.20% of Cardinal Health at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Aventura Private Wealth LLC acquired a new position in Cardinal Health during the 4th quarter valued at $25,000. Elyxium Wealth LLC acquired a new position in Cardinal Health during the 4th quarter valued at $34,000. Barnes Dennig Private Wealth Management LLC raised its stake in Cardinal Health by 38.7% during the 4th quarter. Barnes Dennig Private Wealth Management LLC now owns 190 shares of the company’s stock valued at $39,000 after purchasing an additional 53 shares during the last quarter. JPL Wealth Management LLC acquired a new position in Cardinal Health during the 3rd quarter valued at $31,000. Finally, Turning Point Benefit Group Inc. acquired a new position in Cardinal Health during the 3rd quarter valued at $31,000. 87.17% of the stock is currently owned by institutional investors and hedge funds.

Cardinal Health Stock Performance

CAH opened at $204.56 on Tuesday. The firm’s 50-day simple moving average is $202.47 and its 200-day simple moving average is $208.57. Cardinal Health, Inc. has a twelve month low of $137.75 and a twelve month high of $233.60. The firm has a market cap of $47.91 billion, a price-to-earnings ratio of 31.28, a PEG ratio of 1.12 and a beta of 0.52.

Cardinal Health (NYSE:CAH) last posted its earnings results on Thursday, April 30th. The company reported $3.17 earnings per share for the quarter, topping the consensus estimate of $2.79 by $0.38. Cardinal Health had a net margin of 0.62% and a negative return on equity of 92.61%. The business had revenue of $60.94 billion for the quarter, compared to analyst estimates of $62.10 billion. During the same quarter in the prior year, the firm earned $2.35 EPS. The firm’s quarterly revenue was up 11.0% compared to the same quarter last year. Cardinal Health has set its FY 2026 guidance at 10.700-10.80 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 10.76 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, July 15th. Stockholders of record on Wednesday, July 1st will be issued a $0.5158 dividend. This represents a $2.06 annualized dividend and a dividend yield of 1.0%. The ex-dividend date of this dividend is Wednesday, July 1st. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. Cardinal Health’s payout ratio is currently 31.19%.

Wall Street Analysts Forecast Growth

A number of equities research analysts have weighed in on CAH shares. TD Cowen lifted their price target on shares of Cardinal Health from $251.00 to $255.00 and gave the stock a “buy” rating in a research note on Friday, May 1st. Zacks Research upgraded shares of Cardinal Health from a “hold” rating to a “strong-buy” rating in a research note on Thursday, February 12th. Barclays lifted their price target on shares of Cardinal Health from $243.00 to $258.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 24th. Morgan Stanley lifted their price target on shares of Cardinal Health from $245.00 to $255.00 and gave the stock an “overweight” rating in a research note on Tuesday, April 28th. Finally, JPMorgan Chase & Co. decreased their price target on shares of Cardinal Health from $243.00 to $215.00 and set a “neutral” rating on the stock in a research note on Monday, May 4th. One analyst has rated the stock with a Strong Buy rating, fifteen have issued a Buy rating and two have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $241.80.

About Cardinal Health

Cardinal Health is a multinational healthcare services and products company headquartered in Dublin, Ohio. Tracing its roots to the early 1970s, the company has grown into a major provider of supply chain and distribution services for the healthcare sector. Cardinal Health operates across a range of service lines that support hospitals, health systems, pharmacies, physician offices and clinical laboratories.

The company’s core activities include the wholesale distribution of branded and generic pharmaceuticals, the supply and distribution of medical-surgical products, and the provision of logistics and inventory management solutions.